Mesa Laboratories Tax Provision Over Time
| MLAB Stock | USD 100.86 2.27 2.30% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mesa Laboratories Performance and Mesa Laboratories Correlation. Mesa |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Tax Provision Analysis
Compare Mesa Laboratories and related stocks such as Novanta, Itron Inc, and Fortive Corp Tax Provision Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVT | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.5 M | 13.8 M | 10.2 M | 5 M | 3.9 M | 5.8 M | 13.1 M | 11.3 M | 7.5 M |
| ITRI | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 49.6 M | 74.3 M | (12.6 M) | 20.6 M | 238 K | (45.5 M) | (6.2 M) | 13.3 M | 10.3 M |
| FTV | 405.9 M | 405.9 M | 405.9 M | 405.9 M | 405.9 M | 405.9 M | 270.3 M | 259.3 M | 173.1 M | 149.1 M | 55.5 M | 63.3 M | 118.3 M | 142.5 M | 145.5 M |
| VPG | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 3.2 M | 6.2 M | 10.3 M | 4.1 M | 7.5 M | 5.5 M | 8.5 M | 9.9 M | 6.1 M |
| COHR | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 55 M | 47 M | (96.1 M) | 11.1 M | (96.1 M) |
| ESE | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 22.5 M | 26.4 M | (4.1 M) | 20.4 M | 14.3 M | 17.2 M | 24.1 M | 26.4 M | 30.4 M | 20.4 M |
| ST | (142.1 M) | (142.1 M) | (142.1 M) | (142.1 M) | (142.1 M) | (142.1 M) | 59 M | (5.9 M) | (72.6 M) | 107.7 M | 1.4 M | 50.3 M | 86 M | 73.5 M | 77.1 M |
| FCUV | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 1.6 K | 694 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BMI | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 17.5 M | 20.3 M | 8.1 M | 14.4 M | 15.6 M | 17.7 M | 21.2 M | 29.4 M | 19.5 M |
| VNT | 137.5 M | 137.5 M | 137.5 M | 137.5 M | 137.5 M | 137.5 M | 171.6 M | 150.7 M | 122.1 M | 129.4 M | 118.3 M | 121 M | 126.1 M | 121.5 M | 106.5 M |
Mesa Laboratories and related stocks such as Novanta, Itron Inc, and Fortive Corp Tax Provision description
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.My Equities
My Current Equities and Potential Positions
| Mesa Laboratories | MLAB |
| Classification | Measuring and Control Equipment |
| Location | Colorado; U.S.A |
| Exchange | NASDAQ Exchange |
USD 100.86
Check out Mesa Laboratories Performance and Mesa Laboratories Correlation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Mesa Laboratories technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.